Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, May 22, 2007 (PRIME NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced it will host a live webcast of its annual shareholder meeting scheduled for Thursday, May 24, 2007...
-
NEW YORK, May 9, 2007 (PRIME NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer, will present at the Acumen/BioFin Rodman...
-
NEW YORK, Feb. 9, 2007 (PRIME NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Alan G. Harris, MD, PhD, the company's Chief Medical Officer, will co-chair the upcoming...
-
NEW YORK, Jan. 12, 2007 (PRIME NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) previously reported in its Form 10-QSB for the quarter ended September 30, 2006 that at September 30, 2006, the...
-
NEW YORK, Dec. 14, 2006 (PRIME NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced it will host a live webcast of its annual shareholder meeting scheduled for Friday, December 15,...
-
NEW YORK, Oct. 16, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer, will present at the BIO Investor Forum 2006...
-
NEW YORK, Sept. 19, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Alan G. Harris, MD, PhD, the company's Chief Medical Officer, will chair the upcoming two-day...
-
NEW YORK, Sept. 14, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer, will present at the Oppenheimer 2nd Annual...
-
NEW YORK, Sept. 12, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer, will present at the 3rd Annual Merriman...
-
NEW YORK, Aug. 30, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer of Manhattan Pharmaceuticals, Inc. will be...